STOCK TITAN

ESAB Corp Form 4 Filings

ESAB NYSE

Every Form 4 that ESAB Corp (ESAB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ESAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ESAB filings page.

Rhea-AI Summary

ESAB Corp director Rhonda L. Jordan reported an option exercise and related share sale. On 2026-08-07 she exercised 1,000 stock options at $33.33 per share, acquiring 1,000 common shares, and sold 1,000 common shares at $95.00 per share. Following the option exercise, she held 3,733 options directly. The filing also reports indirect holdings of common stock by family trusts and a spouse, with beneficial ownership disclaimed except to the extent of her pecuniary interest.

Rhea-AI Summary

Bhagwakar Ranjana N reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp reported that EVP, Business Operations Ranjana N. Bhagwakar received a grant of 15,777 restricted stock units on July 15, 2026. Each unit represents a contingent right to one ESAB common share and vests in three equal annual installments, leaving 15,777 units directly held.

Rhea-AI Summary

ESAB Corp EVP of Business Operations Ranjana N. Bhagwakar received new equity awards as part of compensation. On July 1, 2026, she was granted a performance stock option covering 58,056 shares of common stock at an exercise price of $93.69 per share, expiring on June 30, 2033. Vesting of this award occurs in three tranches based on ESAB’s performance over a four-year period starting on the second anniversary of the grant date, and requires continued service through specified anniversaries and performance certification. She also received employee stock options for 7,056 shares at an exercise price of $93.69, vesting in three equal annual installments beginning on the first anniversary of the grant date and expiring on July 1, 2029. In addition, she was granted 9,048 restricted stock units, each representing one share of common stock, which vest in three equal annual installments starting on the first anniversary of the grant date.

Rhea-AI Summary

RALES MITCHELL P reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp Executive Chair Mitchell P. Rales received a grant of 596 deferred stock units (DSUs) on June 30, 2026. These DSUs are payable solely in common stock and will be settled in shares at the earlier of his death or January 31 of the second calendar year after he retires from the Board. Following this grant, he directly holds 16,432 shares of ESAB common stock, with additional indirect holdings reported through a family trust, custodial accounts for his daughters, and a family partnership, some of which he disclaims beneficial ownership except for his pecuniary interest.

Rhea-AI Summary

LUTZ ROBERT S reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp director Robert S. Lutz received a grant of 330 deferred stock units as compensation for Board service. Each unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of his cash retainer, vest immediately, and will be settled in ESAB common stock after he separates from the company.

Rhea-AI Summary

Teirlinck Didier P reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp director Didier P. Teirlinck received a grant of 134 deferred stock units for Board service. These units were issued in lieu of his cash retainer, with each unit representing a contingent right to one share of ESAB common stock.

The deferred stock units vest immediately, meaning the director’s right to them is fully earned on the grant date. They will be settled in ESAB common stock after his separation from the company. Following this grant, Teirlinck holds 134 deferred stock units directly.

Rhea-AI Summary

ESAB Corp reported that Executive Chair of the Board Mitchell P. Rales received a grant of 1,200,000 stock options on June 10, 2026. These performance stock options have an exercise price of $82.92 per share and expire on June 9, 2033.

The options become exercisable, if at all, in three tranches. Vesting depends on ESAB’s simple average closing share price on the NYSE exceeding specified stock price hurdles over any 30-day trailing period during a four-year window starting on the second anniversary of the grant, plus his continued employment through the fourth, fifth and sixth anniversaries and the company’s certification of the price hurdles.

Rhea-AI Summary

ESAB Corp President and CEO Shyam Kambeyanda received a performance stock option grant covering 580,552 shares of ESAB common stock. The option has an exercise price of $82.92 per share and expires on June 9, 2033.

The award vests in three tranches based on ESAB’s achievement of specified performance criteria during a four-year period that starts on the second anniversary of the grant and ends on the sixth anniversary. Vesting also requires Kambeyanda’s continued service through the later of the fourth, fifth and sixth anniversaries of the grant date and the date when performance achievement is certified.

Rhea-AI Summary

ESAB Corp granted Chief Human Resources Officer Michele Campion a performance stock option covering 52,250 shares of common stock at an exercise price of $82.92 per share. The option expires on June 9, 2033 and vests in three tranches tied to multi‑year performance goals and continued service.

Rhea-AI Summary

ESAB Corp granted SVP and General Counsel Curtis E. Jewell a performance stock option covering 58,056 shares of common stock. The option has an exercise price of $82.92 per share and expires on June 9, 2033.

The award vests in three tranches based on ESAB meeting specified performance criteria during a four-year period starting on the second anniversary of the grant date and ending on the sixth anniversary. Vesting also requires Jewell’s continued service through the later of the fourth, fifth and sixth anniversaries and the date when ESAB certifies achievement of the applicable performance goals.

Rhea-AI Summary

ESAB Corp reported that EVP and Chief Financial Officer R. Brent Jones received a grant of performance stock options covering 145,138 shares of common stock at an exercise price of $82.92 per share. These options vest in three tranches based on performance over a four-year period, starting on the second anniversary of the grant date. Vesting also requires his continued service through specified anniversaries and certification that ESAB met the related performance goals.

Rhea-AI Summary

ESAB Corp director Mitchell P. Rales reported several indirect ownership changes involving family entities and trusts. A family partnership affiliated with him received 3,537,797 shares of common stock through contributions from his adult children, a family trust, and a revocable trust, all for no consideration. The filing also shows custodial and trust accounts holding shares for his daughters, for which he disclaims beneficial ownership. In addition, the family partnership acquired 100,000 shares of 6.50% Series A Mandatory Convertible Preferred Stock in a private placement, which will mandatorily convert into ESAB common shares in roughly three years. The preferred stock carries a $1,000 per-share liquidation preference, pays a 6.50% dividend, and will convert into between 7.1806 and 8.2576 common shares per preferred share, subject to customary anti-dilution adjustments and special terms if a Fundamental Change occurs. The filing highlights estate and ownership structuring moves and a private placement investment, rather than open-market buying or selling.

Rhea-AI Summary

ESAB Corp director Melissa Cummings reported a routine equity compensation event involving 637 shares of common stock. On June 1, 2026, 637 Restricted Stock Units vested in a single installment and were exercised at $0.0000 per unit into 637 shares of ESAB common stock, which she now holds directly. A separate line reflects 49.428 shares of common stock held indirectly by her son as of the same date.

Rhea-AI Summary

ESAB Corp director Rajiv Vinnakota exercised equity awards into common stock. On June 1, 2026, 637 restricted stock units, each representing a right to receive one ESAB common share, vested in a single installment and converted into 637 shares of common stock at no stated exercise price. Following this transaction, Vinnakota directly holds 9,378.91 shares of ESAB common stock, and no restricted stock units from this grant remain outstanding.

Rhea-AI Summary

ESAB Corp President and CEO Shyam Kambeyanda reported routine equity compensation activity involving restricted stock units (RSUs). On the reported date, RSUs covering 10,796 shares of common stock vested and were exercised into common shares at a conversion price of $0.00 per share. To cover associated tax obligations, ESAB Corporation withheld 5,053 shares through a net share settlement, as described in the footnotes, and no shares were sold by Kambeyanda on the market to satisfy this tax liability. Following these transactions, he holds 124,944 shares of ESAB common stock directly. The RSU award vests in three equal annual installments, with all remaining RSUs from this grant scheduled to vest on May 12, 2027.

Rhea-AI Summary

ESAB Corp SVP and General Counsel Curtis E. Jewell exercised equity awards and had shares withheld for taxes. On May 12, 2026, he exercised 1,822 restricted stock units into the same number of common shares. In connection with this vesting, 894 shares were withheld by ESAB to cover tax liabilities through net share settlement, and no shares were sold on the market. After these transactions, Jewell directly owned 19,639 common shares and also had 355.835 shares held indirectly through a 401K plan. The restricted stock unit award continues to vest in three equal annual installments, with all remaining units from this award scheduled to vest on May 12, 2027.

Rhea-AI Summary

ESAB Corp Chief Human Resources Officer Michele Campion reported routine equity compensation activity involving restricted stock units. She exercised RSUs covering 1,835 shares of common stock, converting them into directly held shares. In connection with the vesting, 902 shares were withheld by ESAB at a price of $94.20 per share to satisfy her tax liability; no shares were sold in the market. Following these transactions, she directly holds 15,206 shares of common stock and 1,836 restricted stock units that continue to vest according to their schedule.

Rhea-AI Summary

ESAB Corp President, Fab Tech Olivier Biebuyck reported routine equity compensation activity. He exercised 2,362 restricted stock units, receiving the same number of ESAB common shares. In connection with this vesting, 1,184 shares were withheld by ESAB to cover tax obligations, rather than sold in the market.

After these transactions, Biebuyck holds 21,740 ESAB common shares directly. Footnotes state that the restricted stock units vest in three equal annual installments and that remaining units from this award are scheduled to vest on May 12, 2027, reflecting ongoing stock-based compensation rather than discretionary trading.

Rhea-AI Summary

ESAB Corp director Stephanie M. Phillipps reported routine equity compensation awards. She received 813 deferred stock units, each representing one share of ESAB common stock. She also received 2,647 stock options with a $100.94 exercise price that vested and became exercisable on the grant date. The deferred stock units vest in a single installment on June 1, 2027 and will be settled in common stock after her separation from the company.

Rhea-AI Summary

ESAB Corp director Sebastien Martin received new equity awards. On May 8, 2026, he was granted 813 restricted stock units, each representing one share of ESAB common stock, and stock options for 2,647 shares at an exercise price of $100.94 per share.

The stock options vested and became exercisable on the grant date and expire on May 7, 2033. The restricted stock units vest in a single installment on June 1, 2027, aligning part of the director’s compensation with ESAB’s future share performance.

Rhea-AI Summary

ESAB Corp director Melissa Cummings received new equity awards as part of her compensation. On May 8, 2026, she was granted 813 restricted stock units and 2,647 stock options linked to ESAB common stock.

The stock options carry an exercise price of $100.94 per share, vested and became exercisable on the grant date, and are scheduled to expire on May 7, 2033. The restricted stock units each represent a contingent right to receive one share of ESAB common stock and are set to vest in a single installment on June 1, 2027.

These awards are classified as acquisitions under a grant or award, not as open‑market purchases or sales, and result in post‑grant derivative holdings of 813 restricted stock units and 2,647 stock options directly owned by Cummings.

Rhea-AI Summary

ESAB Corp director Rajiv Vinnakota reported receiving new equity awards. On May 8, 2026, he was granted 813 Restricted Stock Units, each representing one share of ESAB common stock. These RSUs vest in a single installment on June 1, 2027.

On the same date, he also received 2,647 stock options with an exercise price of $100.94 per share. According to the disclosure, these options vested and became exercisable on the grant date and expire on May 7, 2033. After these grants, his reported holdings include 813 RSUs and 2,647 options, all held directly.

Rhea-AI Summary

ESAB Corp director Didier P. Teirlinck received new equity awards as part of his compensation. On May 8, 2026, he was granted 406 restricted stock units and 407 deferred stock units, each representing a contingent right to receive one share of ESAB common stock.

The restricted and deferred stock units vest in a single installment on June 1, 2027, with the deferred units to be settled in ESAB common stock after his separation from the company. He also received stock options for 2,647 shares at an exercise price of $100.94 per share, which vested and became exercisable on the grant date and expire on May 7, 2033.

Rhea-AI Summary

ESAB Corp director Robert S. Lutz received new equity-based compensation awards. He was granted 2,647 stock options with an exercise price of $100.94 per share that vested and became exercisable on the grant date. He also received 813 deferred stock units, each representing one share of common stock.

The 813 deferred stock units vest in a single installment on June 1, 2027 and will be settled in ESAB common stock after his separation from the company. These awards are classified as grants rather than open-market purchases or sales and represent routine director compensation.

Rhea-AI Summary

ESAB Corp director Rhonda L. Jordan reported awards of equity-based incentives. She received 813 deferred stock units, each tied to one share of ESAB common stock. These units vest in a single installment on June 1, 2027 and will be settled in stock after her separation from the company.

Jordan was also granted 2,647 stock options with an exercise price of $100.94 per share. According to the disclosure, these options vested and became exercisable on the grant date of May 8, 2026 and will expire on May 7, 2033 if not exercised.

Rhea-AI Summary

ESAB Corp director Mitchell P. Rales reported new equity awards and updated his holdings. On May 8, 2026, he received 813 shares of common stock as an annual equity grant in the form of restricted stock units that vest on June 1, 2027. He also received a stock option for 2,647 shares at an exercise price of $100.94 per share, which is fully vested and exercisable and expires on May 7, 2033. Following these awards, he directly holds 15,836 common shares, with additional indirect holdings through the Mitchell P. Rales Family Trust, a single-member LLC owned by a revocable trust for his benefit, and custodial accounts for his daughter, for which he disclaims beneficial ownership.

Rhea-AI Summary

ESAB Corp reported that EVP and Chief Financial Officer R. Brent Jones received new equity awards. On May 7, 2026, he was granted 14,210 employee stock options to buy common stock at an exercise price of $102.3900 per share, expiring on May 6, 2033. These options vest in three equal annual installments starting on the first day of the month following each of the first three anniversaries of the grant date.

On the same date, Jones was also granted 33,978 restricted stock units, each representing a contingent right to receive one share of ESAB common stock. These RSUs vest in three equal annual installments on the same schedule, aligning his compensation with the company’s future share performance.

Rhea-AI Summary

Han Julie reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp reported that Controller and Principal Accounting Officer Julie Han received a grant of 1,003 restricted stock units on April 1, 2026. Each unit represents a contingent right to receive one share of ESAB common stock. The units vest in three equal annual installments on the first, second and third anniversaries of the grant date. Following this compensation-related award, Han holds 1,003 restricted stock units directly.

Rhea-AI Summary

Teirlinck Didier P reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp director Didier P. Teirlinck received a grant of 123 deferred stock units as Board compensation. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. The units were issued in lieu of his cash retainer, vest immediately, and will be settled in ESAB common stock after his separation from the company.

Rhea-AI Summary

ALLENDER PATRICK W reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp director Patrick W. Allender received 246 deferred stock units as board compensation. Each unit represents a contingent right to one share of ESAB common stock. The units were issued in lieu of his cash retainer, vest immediately, and will be settled in ESAB common stock after he leaves the company.

Rhea-AI Summary

LUTZ ROBERT S reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp director Robert S. Lutz received 304 deferred stock units as board compensation. The units were granted in lieu of his cash retainer, vest immediately, and each represents a right to receive one share of ESAB common stock after he leaves the company.

Rhea-AI Summary

ESAB Corp director Mitchell P. Rales received an equity award of 570 deferred stock units (DSUs) payable in ESAB common stock. These DSUs will convert into shares only at the earlier of his death or January 31 of the second calendar year after he retires from the board. Following the award, he holds 15,023 shares directly. He also has substantial indirect holdings, including shares held through a single-member LLC, a family trust where he serves as trustee, and custodial accounts for his daughter, for which he disclaims beneficial ownership.

Rhea-AI Summary

ESAB Corp officer Renato Negro, Controller PAO, exercised restricted stock units into common stock as part of equity compensation. He converted 986 restricted stock units into 986 shares of common stock at a conversion price of $0.00 per share.

To cover associated tax liabilities on the RSU vesting, 337 shares were withheld by ESAB at a price of $107.02 per share, rather than sold in the market. After these transactions, Negro holds 9,475 shares of ESAB common stock directly, reflecting a net increase of 649 shares from this vesting event.

Rhea-AI Summary

ESAB Corp Chief Financial Officer Kevin J. Johnson reported compensation-related equity transactions. He exercised 2,006 restricted stock units into an equal number of common shares and received a separate stock award of 7,582 common shares. ESAB withheld a total of 4,713 shares, valued at $107.02 per share, to cover tax liabilities upon vesting, with no shares sold on the open market. After these transactions, Johnson directly holds 32,561 shares of ESAB common stock.

Rhea-AI Summary

ESAB Corp President and CEO Shyam Kambeyanda reported routine equity compensation activity involving restricted stock units and common stock. He exercised 6,124 restricted stock units, receiving the same number of ESAB common shares. To cover related tax liabilities, the company withheld a total of 14,244 shares of common stock valued at $107.02 per share; footnotes clarify that no shares were sold by Kambeyanda in the market for these tax payments. He also received a separate grant of 23,146 shares of common stock as a stock award, increasing his direct ownership. Following these transactions, Kambeyanda directly holds 119,201 shares of ESAB common stock, reflecting an overall increase in his equity stake through vesting and awards rather than open‑market trading.

Rhea-AI Summary

ESAB Corp Chief Human Resources Officer Michele Campion reported equity-based compensation activity. She exercised 958 restricted stock units into the same number of common shares and received an additional 3,618 performance-based shares that vested after certification of performance criteria.

To cover related tax liabilities, ESAB withheld 328 shares and 1,468 shares at a reference price of $107.02 per share instead of a cash payment, and no shares were sold by Campion. After these transactions, she directly holds 14,273 shares of ESAB common stock.

Rhea-AI Summary

ESAB Corp director Didier P. Teirlinck exercised a stock option for 3,367 shares of common stock on March 9, 2026. The option had an exercise price of $33.02 per share. Following the transaction, he directly owns 3,367 shares of ESAB common stock, with no shares sold in this filing.

Rhea-AI Summary

ESAB Corp President, Fab Tech Olivier Biebuyck reported compensation-related share activity. He exercised 1,408 restricted stock units into an equal number of common shares and received a separate grant or award of 5,320 common shares. ESAB withheld 662 shares and 2,535 shares at $107.0200 per share to cover tax liabilities on these vestings, with no shares sold on the market. Following these transactions, Biebuyck directly holds 19,378 shares of ESAB common stock.

Rhea-AI Summary

ESAB Corp senior vice president and general counsel Curtis E. Jewell reported routine equity compensation activity. On March 9, 2026, restricted stock units representing 951 shares of common stock converted into shares, and performance-based awards vested, adding a further 3,592 shares. ESAB withheld 449 shares and 1,694 shares at $107.02 per share to cover tax obligations, and the footnotes state no shares were sold in the market. After these transactions, Jewell directly holds 18,711 common shares and indirectly holds 355.835 shares through a 401(k) plan.

Rhea-AI Summary

ESAB Corp Chief Financial Officer Kevin J. Johnson exercised 1,127 restricted stock units into common shares, increasing his direct holdings. On the same date, 554 common shares were withheld by ESAB to cover tax obligations upon vesting, rather than sold in the market.

Rhea-AI Summary

ESAB Corp President, Fab Tech Olivier Biebuyck reported equity compensation activity involving restricted stock units and common shares. He acquired 740 shares of common stock through an exercise or conversion of restricted stock units at a price of $0.0000 per share, increasing his common stock holdings to 16,192 shares. In a related tax-withholding transaction, 345 shares of common stock were withheld at $121.6400 per share to satisfy tax obligations tied to the vesting of restricted stock units, leaving him with 15,847 common shares held directly. Each restricted stock unit represents a right to receive one share of ESAB common stock, and these units vest in three equal annual installments following the grant date.

Rhea-AI Summary

ESAB Corp Chief Human Resources Officer Michele Campion reported a mix of equity transactions tied to restricted stock units. On March 2, 2026, 457 restricted stock units were exercised into 457 shares of common stock at a price of $0.0000 per share.

To cover tax obligations from this vesting, 157 shares of common stock were withheld by ESAB Corporation at $121.6400 per share, with no shares sold by Campion. After these transactions, Campion directly owned 11,493 shares of common stock and 916 restricted stock units, each representing a contingent right to one ESAB share.

Rhea-AI Summary

ESAB Corp officer Renato Negro reported equity award activity involving restricted stock units and common shares. He acquired 509 shares of common stock through the exercise or conversion of 509 restricted stock units, then had 192 common shares withheld at a price of $121.64 per share to cover tax liabilities related to the vesting. After these transactions, he directly owned 8,826 shares of common stock and 1,020 restricted stock units.

Rhea-AI Summary

ESAB Corp President and CEO Shyam Kambeyanda reported equity award activity involving restricted stock units and common shares. He exercised or converted 3,808 restricted stock units, receiving the same number of ESAB common shares at a stated price of $0.00 per share, reflecting the nature of the award.

In a related move, 1,872 common shares were withheld by ESAB Corporation at a price of $121.64 per share to cover the CEO’s tax liability upon vesting, with footnotes clarifying that no shares were sold by him in the market. After these transactions, he directly owned 104,175 ESAB common shares and 7,617 restricted stock units.

Rhea-AI Summary

ESAB Corp senior vice president and general counsel Curtis E. Jewell reported equity compensation activity involving restricted stock units and common shares. He acquired 605 restricted stock units through an exercise or conversion and received 605 common shares at a price of $0.0000 per share.

To cover tax obligations from the vesting of these units, 286 common shares were withheld by ESAB Corporation at $121.6400 per share; no shares were sold by Jewell on the market for this purpose. Following these transactions, he directly held 16,311 common shares.

Each restricted stock unit represents a contingent right to receive one share of ESAB common stock, vesting in three equal annual installments beginning on the first day of the month after each of the first three anniversaries of the grant date. Jewell also indirectly held 355.835 common shares through a 401(k) plan.

Rhea-AI Summary

Negro Renato reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corporation reported that officer Renato Negro, its Controller, PAO, received a grant of 2,077 restricted stock units on February 26, 2026. Each unit represents a contingent right to receive one share of ESAB common stock at a price of $0.00 per unit.

The award vests in three equal annual installments, on the first day of the month following each of the first, second, and third anniversaries of the grant date. After this grant, Negro holds 2,077 restricted stock units directly.

Rhea-AI Summary

Jewell Curtis E reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp senior vice president and general counsel Curtis E. Jewell reported receiving equity compensation awards. He was granted 1,858 restricted stock units and 6,456 employee stock options on common stock, both at a grant price of $0. These awards vest in three equal annual installments starting after each of the first three anniversaries of the grant date.

Rhea-AI Summary

Johnson Kevin J reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp reported that its Chief Financial Officer, Kevin J. Johnson, received new equity compensation awards. On February 26, 2026, he was granted 3,276 restricted stock units, each representing a right to one share of ESAB common stock. These units vest in three equal annual installments starting on the first day of the month following each of the first, second and third anniversaries of the grant date.

On the same date, he was also granted 11,383 employee stock options with a right to buy ESAB common stock. These options vest and become exercisable in three equal annual installments on the same schedule as the restricted stock units.

Rhea-AI Summary

ESAB Corp Chief Human Resources Officer Michele Campion reported a mix of option exercises, stock sales, and new equity awards. She exercised employee stock options for 7,196 shares, then had 4,300 shares withheld by ESAB to cover taxes and exercise costs rather than selling into the market.

Campion also sold a total of 5,096 shares of common stock in open-market transactions around $122.63 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, she directly owned 11,193 ESAB shares. Separately, she received new grants of 5,641 stock options and 1,624 restricted stock units that vest in three annual installments.

Rhea-AI Summary

Kambeyanda Shyam reported acquisition or exercise transactions in this Form 4 filing.

ESAB Corp President and CEO Shyam Kambeyanda reported receiving new equity awards. He was granted 11,657 restricted stock units, each representing the right to receive one ESAB common share, and 40,501 employee stock options with a right to buy ESAB stock.

The restricted stock units vest in three equal annual installments, on the first day of the month following each of the first, second and third anniversaries of the grant date. The stock options follow the same three-year, equal-installment vesting schedule before becoming exercisable.